Individualized treatment effects of high flow nasal oxygen in immunocompromised patients.

Maillard A, Métais M, Lemiale V, Mokart D, Moreau AS, Canet E, Kouatchet A, Buell KG, Jaber S, Argaud L, Wallet F, Pène F, Demoule A, Azoulay E

Open source

DOI
10.1007/s00134-026-08635-8
Published
2026 Nov 2
Container
Intensive care medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00134-026-08635-8,
  title = {Individualized treatment effects of high flow nasal oxygen in immunocompromised patients.},
  author = {Maillard A and Métais M and Lemiale V and Mokart D and Moreau AS and Canet E and Kouatchet A and Buell KG and Jaber S and Argaud L and Wallet F and Pène F and Demoule A and Azoulay E},
  year = {2026},
  journal = {Intensive care medicine},
  doi = {10.1007/s00134-026-08635-8},
  url = {https://doi.org/10.1007/s00134-026-08635-8}
}

RIS

TY  - JOUR
TI  - Individualized treatment effects of high flow nasal oxygen in immunocompromised patients.
AU  - Maillard A
AU  - Métais M
AU  - Lemiale V
AU  - Mokart D
AU  - Moreau AS
AU  - Canet E
AU  - Kouatchet A
AU  - Buell KG
AU  - Jaber S
AU  - Argaud L
AU  - Wallet F
AU  - Pène F
AU  - Demoule A
AU  - Azoulay E
PY  - 2026
JO  - Intensive care medicine
DO  - 10.1007/s00134-026-08635-8
UR  - https://doi.org/10.1007/s00134-026-08635-8
ER  - 

APA

A, M., M, M., V, L., D, M., AS, M., E, C., A, K., KG, B., S, J., L, A., F, W., F, P., A, D., & E, A. (2026). Individualized treatment effects of high flow nasal oxygen in immunocompromised patients.. Intensive care medicine. https://doi.org/10.1007/s00134-026-08635-8

Source records